Literature DB >> 22425246

Nasopharyngeal carcinoma: salvage of local recurrence.

Anne W M Lee1, Willard E Fee, W T Ng, L K Chan.   

Abstract

Local control of nasopharyngeal carcinoma has substantially improved with advancing radiotherapy technology and appropriate combination with chemotherapy. However, when local recurrence occurs, this is one of the most difficult challenges. Aggressive treatment is indicated because long term salvage is achievable particularly for early recurrence, but high risk of complications is a serious concern. Treatment options include different methods of surgery and/or re-irradiation with/without chemotherapy. Available information in the literature is grossly inadequate; most reports compose of small series of highly selected patients with heterogeneous characteristics and treatment. No randomized trials have been performed to evaluate the therapeutic ratio of different treatment methods. This article reviews available treatment options, their therapeutic benefits and risks of complications; the objective is to provide information for developing treatment recommendations and suggestions for future improvement.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22425246     DOI: 10.1016/j.oraloncology.2012.02.017

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  18 in total

1.  The impact of smoking on the clinical outcome of locoregionally advanced nasopharyngeal carcinoma after chemoradiotherapy.

Authors:  Shan-Shan Guo; Pei-Yu Huang; Qiu-Yan Chen; Huai Liu; Lin-Quan Tang; Lu Zhang; Li-Ting Liu; Ka-Jia Cao; Ling Guo; Hao-Yuan Mo; Xiang Guo; Ming-Huang Hong; Hai-Qiang Mai
Journal:  Radiat Oncol       Date:  2014-11-26       Impact factor: 3.481

2.  SOX1 down-regulates β-catenin and reverses malignant phenotype in nasopharyngeal carcinoma.

Authors:  Zhong Guan; Jialiang Zhang; Jing Wang; Hefei Wang; Feimeng Zheng; Jieren Peng; Yaodong Xu; Min Yan; Bing Liu; Bai Cui; Ying Huang; Quentin Liu
Journal:  Mol Cancer       Date:  2014-11-26       Impact factor: 27.401

3.  Combining plasma Epstein-Barr virus DNA and nodal maximal standard uptake values of 18F-fluoro-2-deoxy-D-glucose positron emission tomography improved prognostic stratification to predict distant metastasis for locoregionally advanced nasopharyngeal carcinoma.

Authors:  Wen-Hui Chen; Lin-Quan Tang; Lu Zhang; Qiu-Yan Chen; Shan-Shan Guo; Li-Ting Liu; Wei Fan; Xu Zhang; Ling Guo; Chong Zhao; Ka-Jia Cao; Chao-Nan Qian; Xiang Guo; Dan Xie; Mu-Sheng Zeng; Hai-Qiang Mai
Journal:  Oncotarget       Date:  2015-11-10

4.  The immunologic advantage of recurrent nasopharyngeal carcinoma from the viewpoint of Galectin-9/Tim-3-related changes in the tumour microenvironment.

Authors:  Tseng-Cheng Chen; Chao-Hsien Chen; Cheng-Ping Wang; Pei-Hsuan Lin; Tsung-Lin Yang; Pei-Jen Lou; Jenq-Yuh Ko; Chen-Tu Wu; Yih-Leong Chang
Journal:  Sci Rep       Date:  2017-09-04       Impact factor: 4.379

Review 5.  Nutlin-3, A p53-Mdm2 Antagonist for Nasopharyngeal Carcinoma Treatment.

Authors:  Voon Yee-Lin; Wong Pooi-Fong; Alan Khoo Soo-Beng
Journal:  Mini Rev Med Chem       Date:  2018       Impact factor: 3.862

6.  Development and Validation of Web-Based Nomograms to Precisely Predict Survival Outcomes of Non-metastatic Nasopharyngeal Carcinoma in an Endemic Area.

Authors:  Ji-Jin Yao; Li Lin; Tian-Sheng Gao; Wang-Jian Zhang; Wayne R Lawrence; Jun Ma; Ying Sun
Journal:  Cancer Res Treat       Date:  2020-12-07       Impact factor: 4.679

7.  Endoscope-guided interstitial intensity-modulated brachytherapy and intracavitary brachytherapy as boost radiation for primary early T stage nasopharyngeal carcinoma.

Authors:  Xiang-Bo Wan; Rou Jiang; Fang-Yun Xie; Zhen-Yu Qi; Ai-Ju Li; Wei-Jun Ye; Yi-Jun Hua; Yu-Liang Zhu; Xiong Zou; Ling Guo; Hai-Qiang Mai; Xiang Guo; Ming-Huang Hong; Ming-Yuan Chen
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

8.  5-Azacytidine enhances the radiosensitivity of CNE2 and SUNE1 cells in vitro and in vivo possibly by altering DNA methylation.

Authors:  Wei Jiang; Ying-Qin Li; Na Liu; Ying Sun; Qing-Mei He; Ning Jiang; Ya-Fei Xu; Lei Chen; Jun Ma
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

9.  Neurosurgical interventions for patients with nasopharyngeal carcinoma: a single institution experience.

Authors:  Ke Sai; Yong-gao Mou; Jing Zeng; Yan-chun Lv; Shao-yan Xi; Su Guan; Xiang-heng Zhang; Jian Wang; Chao Ke; Jian-gui Guo; Yin-sheng Chen; Zhong-ping Chen
Journal:  World J Surg Oncol       Date:  2013-09-13       Impact factor: 2.754

10.  MicroRNA-328 inhibits migration and epithelial-mesenchymal transition by targeting CD44 in nasopharyngeal carcinoma cells.

Authors:  Chien-Hung Lin; Ming-Chang Chiang; Yann-Jang Chen
Journal:  Onco Targets Ther       Date:  2018-04-27       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.